XENE Net Income Growth
-47.07%TTM
Period ending:
XENE TTM Net Income YoY %%
603.53%-431.82%
2014-06-302026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
XENE net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 49 observations from Jun 30, 2014 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -47.0718% | |
| -52.3846% | |
| -47.6166% | |
| -43.5573% | |
| -39.7709% | |
| -33.3245% | |
| -28.4753% | |
| -21.9047% | |
| -21.576% | |
| -27.9231% | |
| -45.4803% | |
| -54.1676% | |
| -78.2865% | |
| -78.0814% | |
| -58.9374% | |
| -72.9742% | |
| -55.5215% | |
| -123.046% | |
| -173.5444% | |
| -135.3568% | |
| -111.6068% | |
| 1.6456% | |
| 30.672% | |
| 28.0759% | |
| 36.9911% | |
| 10.3248% | |
| -20.5757% | |
| -14.0366% | |
| -61.8573% | |
| -56.1985% | |
| -12.3534% | |
| -18.7166% | |
| 4.3753% | |
| 1.1339% | |
| -33.5131% | |
| -36.8514% | |
| -67.8988% | |
| -176.4073% | |
| -112.5219% | |
| -269.788% | |
| -331.6254% | |
| -232.8706% | |
| -183.1234% | |
| -139.5583% | |
| -35.9896% | |
| -27.7155% | |
| 46.4013% | |
| 188.8754% | |
| 503.3333% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All XENE financial metrics · XENE stock overview · How to interpret financial metrics
